Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Ophthalmic Goods · Vaughan, ON · filing with the SEC since 2021
Grade4.9
◀ Past 5.8● Present 5.2▶ Future 3.7
Income statement, as filed
In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts in millions. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Feb 18, 2026 | Feb 19, 2025 | Feb 21, 2024 | Feb 22, 2023 | · | · |
| Revenue | 5,101 | 4,791 | 4,146 | 3,768 | 3,765 | 3,412 |
| Research and development | 371 | 343 | 324 | 307 | 271 | 253 |
| Selling, general and administrative | 2,234 | 2,082 | 1,736 | 1,478 | 1,389 | 1,253 |
| Total costs and expenses | 4,988 | 4,629 | 4,016 | 3,561 | 3,436 | 3,152 |
| Operating income | 113 | 162 | 130 | 207 | 329 | 260 |
| Interest expense | 421 | 399 | 283 | 146 | 0 | 0 |
| Interest and investment income | 12 | 15 | 15 | 6 | 0 | 3 |
| Other income (expense), net | · | · | -74 | -13 | -17 | -38 |
| Income before income taxes | -317 | -234 | -166 | 73 | 318 | 290 |
| Income tax expense | 35 | 71 | 82 | 58 | 125 | 307 |
| Net income including non-controlling interests | -352 | -305 | -248 | 15 | 193 | -17 |
| Net income to non-controlling interests | 8 | 12 | 12 | 9 | 11 | 1 |
| Net income | -360 | -317 | -260 | 6 | 182 | -18 |
| Earnings per share, basic | -1.02 | -0.90 | -0.74 | 0.02 | 0.52 | -0.05 |
| Earnings per share, diluted | -1.02 | -0.90 | -0.74 | 0.02 | 0.52 | -0.05 |
| Weighted average shares, basic | 353.8 | 351.8 | 350.5 | 350.0 | 350.0 | 350.0 |
| Weighted average shares, diluted | 353.8 | 351.8 | 350.5 | 350.2 | 350.0 | 350.0 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseDebtInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding